
Povetacicept led to a significantly greater reduction in the 24-hour urinary protein-to-creatinine ratio (UPCR) than placebo by week 36 in participants with IgA nephropathy #IgAN ca. 2026 from @NEJM #Nephpearls #KidneyWk #VisualAbstract by @DrAkshayaJ 👉 nejm.org/doi/full/10.1056/NE…




























